A commonly occurring polymorphism upstream of the estrogen receptor alpha alters transcription and is associated with increased HDL

« Previous Next »Atherosclerosis
Volume 199, Issue 2 , Pages 354-361, August 2008

Gemma A. Figtree
- Department of Cardiovascular Medicine, Wellcome Trust Centre for Human Genetics, University of Oxford, UK
- Kolling Institute of Medical Research, University of Sydney, Australia
- Corresponding author at: Department of Cardiology, Royal North Shore Hospital, University of Sydney, St Leonards, NSW 2065, Australia. Tel.: +61 2 9926 7111; fax: +61 2 9906 1355.
Stuart M. Grieve
- Kolling Institute of Medical Research, University of Sydney, Australia
Bridget Speller
- Kolling Institute of Medical Research, University of Sydney, Australia
Mary-Jane Geiger
- Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, United States
Bruce G. Robinson
- Kolling Institute of Medical Research, University of Sydney, Australia
Keith M. Channon
- Kolling Institute of Medical Research, University of Sydney, Australia
Jiannis Ragoussis
- Department of Cardiovascular Medicine, Wellcome Trust Centre for Human Genetics, University of Oxford, UK
Peter Collins
- Cardiac Medicine, National Heart and Lung Institute, Imperial College, London, UK
Hugh Watkins
- Department of Cardiovascular Medicine, Wellcome Trust Centre for Human Genetics, University of Oxford, UK